Skip to main content
SpringerLink
Log in

Correlation study of Carcino Embryonic Antigen & Cancer Antigen 15.3 in pretreated female breast cancer patients

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Carcino Embryonic Antigen (CEA) and Cancer Antigen 15.3 (CA15.3) are the most common tumor markers in breast cancer patients. Measurement of circulating tumor markers is a non-invasive quantitative method. Serum levels of CEA and CA 15.3 were studied in female breast cancer patients prior to treatment. To evaluate the utility of these markers, 207 Breast carcinoma patients belonging to all the stages were considered. Healthy age matched 75 female individuals formed the control group. The serum levels of CEA and CA 15.3 were analyzed by Enzyme Linked Immunosorbent Assay (ELISA). Results were taken and compared with stages, tumor size, node and grade. The serum CA 15.3 levels were significant in all the study parameters whereas serum CEA levels showed no significant changes with any of the parameters. Measurement of serum CA 15.3 levels showed significant correlation (24.8%) with advanced stages and larger tumor sizes, whereas serum CEA levels did not show any significant correlation in breast cancer patients prior to treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439–62.

    Article  PubMed  CAS  Google Scholar 

  2. Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991; 5: 344–66.

    Article  PubMed  CAS  Google Scholar 

  3. Thomas P, Toth CA, Saini KS, Jessup JM, Steele G. The structure, metabolism and function of the carcinoembryonic antigen gene family. Biochem Biophys Acta 1990; 1032: 177–89.

    PubMed  CAS  Google Scholar 

  4. Duffy MJ. CA15.3 and related mucins as circulating markers in breast cancer. Ann Clin Biochem 1999; 36: 579–86.

    PubMed  CAS  Google Scholar 

  5. Duffy MJ, Shering S, Sherry F, McDermott E, O'Higgins N. CA15.3: a prognostic marker in breast cancer. Int J Biol Markers 2000; 15: 330–33.

    PubMed  CAS  Google Scholar 

  6. Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumour Biol 1998; 19: 1–20.

    Article  PubMed  Google Scholar 

  7. Duffy MJ, Duggan C, Keane R, Arnold DK, Hill, McDermott E. et al. High preoperative CA15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: Study of 600 patients with histologically confirmed breast cancer. Clinical Chemistry 2004; 50:559–63.

    Article  PubMed  CAS  Google Scholar 

  8. Coveney EC, Geraghty JG, Sherry F, McDermott EW, Fennelly JJ, O'Higgins NJ. The clinical value of CEA and CA 15-3 in breast cancer management. Int J Biol Markers 1995; 10: 35–41.

    PubMed  CAS  Google Scholar 

  9. Busetto M, Vianello L, Franceschi R, Bolzan M. CA 15-3 value and neoplastic disease predictivity in the follow-up for breast cancer. Tumour Biol 1995; 16: 243–53.

    Article  PubMed  CAS  Google Scholar 

  10. Giai M, Roagna R, Ponzone R, Biglia N, Sgro L, Perona M. et al. TPS and CA15.3 serum values as a guide for treating and monitoring breast cancer patients. Anti-cancer Research 1996; 16: 875–82.

    CAS  Google Scholar 

  11. Nalini R, Delphine W, Silvia CR, Makhija PM, Uthappa S. Usefulness of serum CA 15.3 and Histopathological prognostic indices in breast cancer. Ind J Clin Biochem 2005; 20: 165–8.

    Article  Google Scholar 

  12. Vizcara E, Lluch A, Cibrian R, Jarque F, Garcia conde J. CA 15.3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse. Oncology 1994; 51: 491–6.

    Google Scholar 

  13. Robertson JFR, Pearson D, Price MR, Selby C, Blamey RW, Howell A. Objective measurement of therapeutic response in breast cancer using tumor markers Br J Cancer 1991; 64: 757–63.

    PubMed  CAS  Google Scholar 

  14. Pentheroudakis G, Malamou-Mitsi V, Briasoulis E, Damala K, Vassou A, Vartholomatos G. et al. The neutrophil not the tumor. Cancer 2004; 101: 1767–75.

    Article  PubMed  CAS  Google Scholar 

  15. Safi F, Kohler I, Rottinger E, Beger HE. The value of the tumor marker CA 15.3 in diagnosing and monitoring breast cancer. Cancer 1991; 68: 574–82.

    Article  PubMed  CAS  Google Scholar 

  16. Tondini C, Hayes DF, Kufe DW. Circulating tumor markers in breast cancer. Hematol/Onco Clin North Am 1989; 3: 653–74.

    CAS  Google Scholar 

  17. Ali SM, Leitzel K, Chinchilli VM, Engle L, Demers L, Harvey HA. et al. Relationship of serum Her-2/neu and serum CA15.3 in patients with metastatic breast cancer. Clinical Chemistry 2002; 48: 1314–20.

    PubMed  CAS  Google Scholar 

  18. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR. Prognostic factors in colorectal cancer. Arch Pathol Lab Med 2000; 124: 979–94.

    PubMed  CAS  Google Scholar 

  19. Harrison LE, Guillem JG, Paty P, Cohen AM. Preoperative carcinoembryonic antigen predicts outcome in node negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg 1997; 185: 55–9.

    PubMed  CAS  Google Scholar 

  20. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrence of colorectal cancer, a prospective randomized study. Dis Colon Rectum 1998; 41: 1127–33.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Kidwai Memorial Institute of Oncology, Hosur Road, 560 029, Bangalore, Karnataka

    K. Thriveni, Lakshmi Krishnamoorthy & Girija Ramaswamy

Authors
  1. K. Thriveni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lakshmi Krishnamoorthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Girija Ramaswamy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Girija Ramaswamy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thriveni, K., Krishnamoorthy, L. & Ramaswamy, G. Correlation study of Carcino Embryonic Antigen & Cancer Antigen 15.3 in pretreated female breast cancer patients. Indian J Clin Biochem 22, 57–60 (2007). https://doi.org/10.1007/BF02912882

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02912882

Key words

Search

Navigation